You are here

Bayer, EDB to fund S$30m regional disease research

Effort will deepen cancer research and expand into heart and eye diseases

Prof Busch, head of Bayer's global drug discovery division, said "by working with our partners, we can gain first-hand insight into diseases prevalent in Singapore and Asia, and gather a real-life perspective into their clinical management practice".


PHARMACEUTICAL giant Bayer HealthCare and the Singapore Economic Development Board (EDB) will jointly foster translational and clinical research for diseases prevalent in Asia over the next five years, they announced at a launch ceremony on Wednesday.

EDB will facilitate

Market voices on: